Eurofins Records Steady Organic Growth in Nine-Month Period of 2025

Eurofins Scientific SE reported a 5.3% increase in revenues for the first nine months of 2025, reaching €5,415 million compared to the same period in 2024. This growth was driven by a 4.0% organic revenue increase and strategic acquisitions, despite challenges from foreign exchange rates as the Euro strengthened against other currencies.

Across regions, Europe and North America each experienced a 3.5% organic growth, while the Rest of the World saw an impressive 8.4% rise. Contributions from start-ups added 0.6% to the organic growth figure.

For the full year 2025, Eurofins is on track to achieve its financial objectives, forecasting improvements in EBITDA margin despite a potential 1.6% revenue growth headwind from the US Dollar. Future performance is expected to benefit from ongoing innovations and strategic investments.